Clinical Trial Update: Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries [Phase 2, Phase 3]

View source ↗

Summary

This completed Phase 2/3 trial evaluated using a paclitaxel-eluting balloon to prevent restenosis after Genous stent implantation in coronary arteries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Genous stent (Genous stent)
• Paclitaxel-eluting balloon (paclitaxel)

Snippet

Sponsor: University of Ulm | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED